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Abstract 
Citrus fruits, which are cultivated worldwide, have been recognized as some of the most high-consumption fruits in 
terms of energy, nutrients and health supplements. What is more, a number of these fruits have been used as tradi-
tional medicinal herbs to cure diseases in several Asian countries. Numerous studies have focused on Citrus secondary 
metabolites as well as bioactivities and have been intended to develop new chemotherapeutic or complementary 
medicine in recent decades. Citrus-derived secondary metabolites, including flavonoids, alkaloids, limonoids, cou-
marins, carotenoids, phenolic acids and essential oils, are of vital importance to human health due to their active 
properties. These characteristics include anti-oxidative, anti-inflammatory, anti-cancer, as well as cardiovascular pro-
tective effects, neuroprotective effects, etc. This review summarizes the global distribution and taxonomy, numerous 
secondary metabolites and bioactivities of Citrus fruits to provide a reference for further study. Flavonoids as charac-
teristic bioactive metabolites in Citrus fruits are mainly introduced.
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Background
Citrus fruits, which belong to the genus Citrus of the 
family Rutaceae, are of various forms and sizes (from 
round to oblong), commonly known as oranges, man-
darins, limes, lemons, grapefruits and citrons. The sen-
sory attributes of fruits (color, sweet taste, bitterness, 
and astringency) constitute decisive organoleptic and 
commercial properties [1]. Citrus species are consumed 
mainly as fresh or raw materials for juices or are canned 
as segments. Additionally, Citrus fruits can also be used 
in the food, beverage, cosmetic and pharmaceutical 
industries as additives, spices, cosmetic ingredients and 
chemoprophylactic drugs, respectively [2, 3].
Citrus fruits are good sources of nutrition with an 
ample amount of vitamin C. Besides, the fruits are abun-
dant in other macronutrients, including sugars, dietary 
fiber, potassium, folate, calcium, thiamin, niacin, vitamin 
B6, phosphorus, magnesium, copper, riboflavin and pan-
tothenic acid [4]. However, secondary metabolites are an 
especially popular topic in the present research. These 
constituents, also known as phytochemicals, are small 
molecules that are not strictly necessarily for the survival 
of the plants but represent pharmacological activity. Cit-
rus fruits contain a number of secondary metabolites, 
such as flavonoids, alkaloids, coumarins, limonoids, 
carotenoids, phenol acids and essential oils. These active 
secondary metabolites show several bioactivities of vital 
importance to human health, including anti-oxidative, 
anti-inflammatory, anti-cancer, as well as cardiovascular 
protective effects, neuroprotective effects, etc. In addi-
tion, Citrus fruits have been used as traditional medici-
nal herbs in several Asian countries, such as China, Japan 
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and Korea. Nine traditional Chinese medicines have 
been recorded in the Chinese Pharmacopoeia for appro-
priate medical use from six Citrus species [5]: C. reticu-
lata Blanco, C. medica L. var. sarcodactylis Swingle, C. 
medica L., C. wilsonii Tanaka, Citrus aurantium L. and 
C. sinensis Osbeck. These peels or whole fruits (mature 
or immature) are known to treat indigestion, cough, skin 
inflammation, muscle pain, and ringworm infections, as 
well as to lower blood pressure.
This review summarizes the global distribution and 
taxonomy, numerous secondary metabolites and bio-
activities related to human health of Citrus fruits. Espe-
cially, flavonoids as the main characteristic metabolites in 
Citrus fruits, which can provide benefit for human health 
based on their multiple bioactivities. Then, the secondary 
metabolites variation among different species and fruit 
parts were mentioned to provide a better guide for our 
daily use and related industries.
Distribution and taxonomy
According to statistics of FAOSTAT [6], Citrus species 
are grown all over the world in more than 140 countries, 
with more than 8.7 million hectares and about 131 mil-
lion tons of fruits produced in 2012. And China, Brazil, 
the U.S.A., India, Mexico, and Spain are the world’s lead-
ing Citrus fruit-producing countries (see Fig.  1a), rep-
resenting close to two-thirds of global production. In 
China, citriculture has existed traditionally, and the Cit-
rus varieties have been naturally selected [7] (see Fig. 1b): 
(1) C. aurantifolia (Christm.) Swingle, (2) C. aurantium 
L., (3) C. hongheensis Ye et al., (4) C. hystrix DC., (5) C. 
ichangensis Swingle, (6) C. junos Sieb. ex Tanaka, (7) C. 
limon (L.) Burm. f., (8) C. limonia Osb., (9) C. macroptera 
Montrous., (10) C. maxima (Burm.) Merr., (11) C. med-
ica L., (12) C. paradisi Macf., (13) C. reticulata Blanco, 
(14) C. sinensis (L.) Osb.
The genus Citrus belongs to the subtribe Citrinae, tribe 
Citreae, subfamily Aurantioideae of the family Rutaceae. 
However, continual taxonomic study appears to be very 
complicated and controversial, mainly due to sexual com-
patibility between Citrus species and related genera, the 
high frequency of bud mutations, apomixis (e.g., adven-
titious embryony) [8]. Consequently, there has been no 
consensus among taxonomists as to the actual number 
of Citrus species. The most widely accepted taxonomic 
systems for Citrus are those of Swingle and Reece [9] 
and Tanaka [10], who recognized 16 and 162 species, 
respectively. Later, phylogenetic analysis indicated only 
three true species within the cultivated Citrus [11], i.e., C. 
medica L. (citron), C. reticulata Blanco (mandarin) and 
C. maxima (Burm.) Merr. (pummelo). In order to be con-
venient, the existing taxonomic systems are combined 
currently.
Because morphological characters are of limited use, 
studies have mainly focused on new taxonomy methods, 
i.e., chemotaxonomy. 66 Citrus species and near-Citrus 
relatives can be cited in accordance with Tanaka’s classi-
fication system with 24 flavonoids [12]. Flavanones were 
used as chemotaxonomic markers to distinguish 77 Zhi-
shi (traditional Chinese medicine) samples from three 
Citrus species [13]. Another study suggested that the 
content of certain monoterpenes could be as taxonomic 
markers between C. sinensis Osbeck and C. junos Sieb. ex 
Tanaka [14].
Active secondary metabolites
Plentiful active natural metabolites including flavonoids, 
alkaloids, coumarins, limonoids, carotenoids, phenolic 
acids and essential oils, have been found in Citrus fruits. 
Tables in additional files have summarized these second-
ary metabolites isolated from peel, pulp, seed, pressed 
oil, juice or whole fruit from 31 common species to give 
a systematical profile. By these at least, the types of Cit-
rus-derived secondary metabolites vary among different 
Citrus species and different fruit parts. Moreover, fla-
vanones, synephrine, auraptene and limonin are the most 
dominants among the flavonoids, alkaloids, coumarins 
and limonoids groups, respectively.
In Additional file  1, 48 types of flavonoids from 22 
common Citrus species of different fruit parts (peel, 
pulp, seed, pressed oil, juice or whole fruit) have been 
summarized. These flavonoids belong to the five classes: 
flavones, flavonols, flavanones, flavanonols and poly-
methoxylated flavones. Anthocyanins, an uncommon 
class of flavonoid, only appears in blood oranges of 
limited data in different fruit parts [15]. Among Citrus-
derived flavonoids, flavanones comprise approximately 
95 % of the total flavonoids [16]. And flavones, flavonols 
and polymethoxylated flavones present in lower con-
centration. In addition, some of flavonoids are unique to 
Citrus plants. Citrus-derived flavonoids are present in 
glycoside or aglycone forms, and usually do not occur 
naturally as aglycones but rather as glycosides, in which 
the aglycones are linked to a sugar moiety [17]. Among 
the aglycone forms, naringenin, hesperetin, apigenin, 
nobiletin, tangeretin and quercetin are widely detected 
(see Additional file  1). For glycoside forms, O-glyco-
sides, C-glycosides, rutinosides, glucosides and neohes-
peridosides are common. Naringin (neohesperidoside), 
neohesperidin (neohesperidoside), narirutin (rutino-
side), and hesperidin (rutinoside) are commonly present 
in major quantities. Sinensetin, isosinensetin, nobiletin, 
tangeretin, which all belong to polymethoxylated fla-
vones, exist only as aglycones because the binding sites 
for sugar moieties are not occupied by hydroxyl moie-
ties [18].
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In Additional file  2, alkaloids, coumarins, limonoids, 
carotenoids, phenolic acids and essential oils have also 
been well summarized from different Citrus species and 
different fruit parts. Active alkaloids are abundant in C. 
aurantium compared to other Citrus species, especially 
synephrine, which comprises more than 85 % of the total 
protoalkaloid content [19]. Additionally, N-methylt-
yramine has been found at much higher concentrations 
than octopamine, tyramine or hordenine [20]. Coumarins 
are commonly found in Citrus plants (high concentra-
tion in peels). Auraptene (7-geranyloxycoumarin) is a 
major coumarin in Citrus plants. Limonoids are unique 
compounds occurring in the Meliaceae and Rutaceae 
family. Citrus (a genus in the family Rutaceae) limonoids 
are highly oxygenated triterpenoids, which are present 
as aglycones, glucosides, and A-ring lactones. Also, Cit-
rus limonoids are the metabolic precursors to limonoid 
aglycones and glucosides [21]. Limonin and limonin glu-
coside (see Additional file 2) are the most abundant limo-
noids for the majority of Citrus species. Carotenoids are 
a large family of isoprenoid compounds that impart yel-
low, orange, and red pigments to many plants as well as 
the yellow-to-orange color of Citrus fruits. Lutein, zeax-
anthin and β-cryptoxanthin, β-carotene, can be found 
in significant quantities in tangerines and oranges ([22], 
see Additional file 2). Investigations have shown that the 
majority of phenolic acids in Citrus fruits are present in 
bound forms [23].
In Additional file 3, Citrus-derived volatile compounds 
from 15 common Citrus Species have been summarized. 
These compounds are roughly divided into 6 groups: 
monoterpene hydrocarbons, sesquiterpene hydrocar-
bons, alcohols, aldehydes, esters & ketones and Oxides. 
These volatile compounds are mainly come from peels 
of Citrus fruits that have many oil chambers of unique 
aroma flavors, differ depending on the species and 
variety.
Bioactivities
Owing to these metabolites, Citrus fruits exhibit plentiful 
bioactivities including anti-oxidant, anti-inflammatory, 
anti-cancer, anti-microbial and anti-allergy activities, 
as well as cardiovascular effect, neuroprotective effect, 
hepatoprotective effect, obesity control, etc. Note that 
Fig. 1 a Top six Citrus fruits-producing countries in the world. Citrus species are grown in 140 countries, though production shows geographical 
concentration in certain areas. China, Brazil, the USA, India, Mexico, and Spain are the world’s top 6 Citrus fruit-producing countries, representing 
close to two-thirds of global production. China is the first leading country as producers which had produced 32,221,345 tons of Citrus fruit in 2012. 
Brazil is the second production country of Citrus fruits with 20,258,507 tons in 2012. And the USA. India, Mexico and Spain also play dominant 
roles in Citrus production which all produced more than 5,000,00 tons in 2012. b Distribution of 14 Citrus-varieties in the major Citrus-producing 
provinces of China. There are 14 Citrus varieties distributed in 13 provinces in China. (1) C. aurantifolia (Christm.) Swingle is mainly distributed in 
Yunnan province; (2) C. aurantium L. is mainly distributed in Fujian, Guangdong, Guangxi, Guizhou, Hainan, Hubei, Hunan, Jiangsu, Shaanxi, Sichuan, 
Yunnan, Zhejiang, provinces; (3) C. hongheensis Ye et al. is mainly distributed in Yunnan province; (4) C. hystrix DC. is mainly distributed in Guangxi, 
Yunnan province; (5) C. ichangensis Swingle is mainly distributed in Gansu, Guangxi, Guizhou, Hubei, Hunan, Shaanxi, Sichuan, Yunnan provinces; (6) 
C. junos Sieb. ex Tanaka is mainly distributed in Gansu, Guangxi, Guizhou, Hubei, Hunan, Jiangsu, Shaanxi, Yunnan provinces; (7) C. limon (L.) Burm. f. 
is mainly distributed in Fujian, Guangdong, Guangxi, Guizhou, Hunan, Yunnan, Zhejiang provinces; (8) C. limonia Osb. is mainly distributed in Fujian, 
Guangdong, Guangxi, Guizhou, Hunan, Yunnan provinces; (9) C. macroptera Montrous. is mainly distributed in Hainan, Yunnan provinces; (10) C. 
maxima (Burm.) Merr. is mainly distributed in Fujian, Guangdong, Guangxi, Guizhou, Hunan, Jiangsu, Yunnan, Zhejiang provinces; (11) C. medica L. 
is mainly distributed in Fujian, Guangdong, Guangxi, Hainan, Yunnan provinces; (12) C. paradisi Macf. is mainly distributed in Guangdong, Sichuan, 
Zhejiang provinces; (13) C. reticulata Blanco is mainly distributed in Fujian, Guangdong, Guangxi, Guizhou, Hainan, Hubei, Hunan, Jiangsu, Shaanxi, 
Sichuan, Yunnan, Zhejiang provinces; (14) C. sinensis (L.) Osb. is mainly distributed in Fujian, Gansu, Guangdong, Guangxi, Guizhou, Hainan, Hubei, 
Hunan, Jiangsu, Shaanxi, Sichuan, Yunnan, Zhejiang provinces
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flavonoids (especially flavanone, flavanonol and meth-
oxylated flavones) are more active compared to other 
secondary metabolites in Citrus for their remarkable var-
ious bioactivities. Studies on plentiful bioactivities from 
hesperetin/hesperidin (flavanone) [24–28], naringenin/
naringin (flavanone) [29–34], tangeretin (polymethoxy-
latedflavone) [35–37] and nobiletin (polymethoxylated-
flavone) [36, 38–41] have been widely reported.
Anti‑oxidant
Reactive oxygen species (ROS) are chemically derived 
from oxygen such as superoxide anion, hydroxyl radicals 
and hydrogen peroxide in living organisms by amount of 
metabolism pathways, while anti-oxidant system is able 
to defend against it to keep balance [42]. However, mod-
ern lifestyle involves a number of factors that may raise 
the level of ROS which play a critical role in the patho-
genesis of various diseases such as aging, arthritis, can-
cer, inflammation, and heart disease, and cause oxidative 
stress. Citrus extracts such as Citrus karna peel extracts, 
Citrus  limetta peel extracts and Citrus bergamia juice 
extracts were found to have potential antioxidant bioac-
tivity [43–45]. Citrus fruits are reported to have a good 
anti-oxidant ability especially because of their phenolic 
compounds with poly-hydroxyl groups, including phe-
nolic acids, flavonoids and their derivatives [46]. The pri-
mary anti-oxidant mechanisms of phenolic compounds 
are listed below:
  • Direct absorption and neutralization of free radicals 
[47].
  • Inhibition of enzymes associated with ROS pathways: 
NADPH oxidase, xanthine oxidase and myeloperoxi-
dase [48].
  • Enhancement of the activities of human anti-oxidant 
enzymes: superoxide dismutase, catalase, etc. [49].
Flavonoids
The juices from green and ripe chinotto (C. myrtifolia 
Raf.), which were full of flavonoid, was tested by DPPH· 
radical bleaching and superoxide-anion scavenging, and 
it was shown that immature chinotto fruits, in particu-
lar, yield a juice with a remarkable anti-oxidant power 
[50]. The anti-oxidant activity of the flavonoid mixture 
isolated from the Citrus peel was determined in terms 
of the DPPH· and ABTS·+ scavenging and the reduc-
ing power assay in a concentration range from 25 to 
500  mg/L, and its anti-oxidant activity increased in a 
dose-dependent manner [51]. Sun et al. [52] using FRAP, 
DPPH, and ABTS assays detected immature fruits drops 
of nine Citrus varieties cultivated in China and deter-
mined that the anti-oxidant activity, which varied signifi-
cantly among the species, was highest in Citrus poonensis 
Hort. ex Tanaka and Citrus unshiu Marc. cv Owari and 
lowest in Citrus paradise Macf. Changshanhuyou, Cit-
rus grandis (L.) Osbeck cv Foyou, and Citurs limon (L.) 
Burm.f. cv Eureka. Different anti-oxidant assays have 
applied to evaluate anti-oxidant activity. For instance, 
quercetagetin showed strong DPPH radical-scavenging 
activity (IC50 7.89  mol  L−1) but much lower hydroxyl 
radical-scavenging activity (IC50 203.82  µmol  L−1). In 
vivo, hesperetin was administered orally and acted as a 
potent antioxidative agent against Cd-induced testicular 
toxicity in rats [24]. Hesperetin increased the glutathione 
and glutathione dependent enzymes in the testes of rats, 
by which it effectively reduced the Cd-induced oxida-
tive stress and restored the activities of ATPases. Aran-
ganathan and Nalini reported that hesperetin exerted 
an anti-lipoperoxidative effect and thereby restored the 
membrane-bound ATPase activity in Cd-intoxicated rat 
testes [53].
Phenolic acids
There were positive correlations among the results of the 
anti-oxidant capacities and total phenolic acids contents 
of the Tarhana samples [54]. The anti-oxidant potency 
composite index showed wide variations, ranging from 
58.84 to 98.89 in the 14 studied wild mandarin genotypes 
native to China, due to different phenolic compounds’ 
levels, including phenolic acids. Ogiwara et al. [55] found 
that caffeic, chlorogenic, and ferulic acids scavenged vari-
ous radicals, such as superoxide anions and hydroxy radi-
cals. Citric acids from Citrus have been found to show 
anti-oxidant activity in lipopolysaccharide (LPS)-treated 
mice [56]. Korani et  al. [57] demonstrated that gallic 
acid has a beneficial activity against 2VO-induced cog-
nitive deficits via enhancement of the cerebral anti-oxi-
dant defense. Among the phenolic acid group, gallic acid 
with three hydroxyl groups on the aromatic ring was the 
strongest anti-oxidant [58]. In contrast, the monosubsti-
tuted phenolic acids (p-coumaric acid, o-coumaric acid, 
and 4-OH-phenylacetic acid) showed very low activity. 
In addition, the radical-scavenging activities of phenolic 
acids are related to their hydroxyl group characteristics 
in the order: gallic > gentisic >  syringic > caffeic > pro-
tocatechuic  >  sinapic  >  ferulic  >  isoferulic  >  vanil-
lic  >  p-coumaric  >  o-coumaric  >  m-coumaric  >  sali-
cylic ≫ p-hydroxybenzoic [59].
Essential oils
Singh et al. [60] reported that monoterpenic essential oils 
were natural anti-oxidants. Choi et al. [61] found that the 
radical-scavenging activity of 34 types of Citrus essential 
oils on DPPH ranged from 17.7 to 64 %. These activities 
were determined to be higher when the oils contained 
geraniol, terpinolene and γ-terpinene. However, the 
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bioactivity of the essential oils generally resulted from a 
complex interaction between its constituents, which pro-
duced both synergistic and antagonistic responses [62].
Coumarins
The accumulating data from studies revealed that dihy-
droxycoumarins were better anti-oxidants than monohy-
droxycoumarins and that the OH groups positioned near 
C6 and C7 in the coumarin skeleton played an important 
role in the inhibition of mushroom tyrosinase [63].
Anti‑inflammatory
Inflammation is a very complex response that is medi-
ated by inflammatory cytokines including tumor necrosis 
factor-alpha (TNF-α), interleukin-1β and interleukin-6 
as well as a cascade of molecular mediators including 
inducible nitric oxide synthase (iNOS), cyclooxygenase-2 
(COX-2), which are all closely regulated by the organ-
ism. And these inflammatory cytokines are active in the 
pathogenesis of various chronic inflammatory diseases 
such as multiple sclerosis, Parkinson’s disease, Alzhei-
mer’s disease and colon cancer [64]. Orange (C. auran-
tium L.) peel extract was found to suppress UVB-induced 
COX-2 expression and PGE2 production in HaCaT cells, 
and acted as a peroxisome proliferator-activated receptor 
(PPAR)-c agonist [65]. Flavonoids, coumarin and vola-
tile oil from Citrus fruit are showing anti-inflammatory 
activity, which can be used as supplement to protect 
against or ameliorate this chronic inflammatory diseases.
Flavonoids
Naringin reduced lipopolysaccharide- or infection-
induced endotoxin shock in mice, attenuated chronic 
pulmonary neutrophilic inflammation in cigarette 
smoke-exposed rats [29]. And its aglycone, naringenin, 
exerted anti-inflammatory activities in macrophages 
and in human blood [66]. Hesperidin exerted notice-
able in vivo anti-inflammatory systemic effects in mouse 
models of LPS-induced lung inflammation and of endo-
toxin-induced infection [25], in rat models of rheuma-
toid arthritis and against inflammation in mouse skin 
[26]. Nobiletin dose-dependently reduced the nitric 
oxide (NO) levels and decreased iNOS expression at 
the protein, mRNA and antisense transcript levels [38]. 
Sudachitin had been found to inhibit NO production by 
suppressing the expression of iNOs in LPS-stimulated 
macrophages, to exhibit anti-inflammatory activity, and 
was a more potent anti-inflammatory agent than nobi-
letin [67]. In addition, quercetin was known to possess 
strong anti-inflammatory capacities [68]. Data suggested 
that flavone suppresses iNOS expression via a mecha-
nism that was similar to that of nobiletin and that the 
flavone skeleton was essential for the suppression of NO 
and iNOS [69]. Although many types of flavonoids exhib-
ited anti-inflammatory activity, hesperidin and diosmin 
did not cause significant decreases in NO production in 
RAW264.7 cells [38].
Essential oils
C. latifolia Tanaka volatile oil and its main constituent 
limonene decreased the infiltration of peritoneal exudate 
leukocytes and the number of polymorphonuclear leu-
kocytes in zymosan-induced peritonitis, and additionally 
reduced TNF-α levels (but not IL-10 levels) in the perito-
neal exudates [70]. Citropten and bergapten from berga-
mot oil, were found as strong inhibitors of interleukin-8 
(IL-8) expression, and could be proposed as potential 
anti-inflammatory molecules to reduce lung inflamma-
tion in patients with cystic fibrosis [71].
Coumarins
Auraptene exhibited anti-inflammatory activities by sup-
pressing the production of inflammatory factors that 
mediated the interaction between adipocytes and mac-
rophages [72]. Another coumarin, imperatorin, also 
showed anti-inflammatory activity in LPS-stimulated 
mouse macrophage (RAW264.7) in  vitro and a carra-
geenan-induced mouse paw edema model in  vivo [73]. 
Besides, imperatorin blocked the protein expression of 
iNOs and COX-2 in LPS-stimulated RAW 264.7cells. 7, 
8-dimethoxycoumarin (100  mg/kg) from C. decumana 
peels showed ameliorative effect on gastric inflammation 
[74].
Anti‑cancer
Citrus fruits are high in secondary metabolites, includ-
ing flavonoids, limonoids, and coumarins, which are 
associated with a reduced risk of cancer, including gas-
tric cancer, breast cancer, lung tumorigenesis, colonic 
tumorigenesis, hepatocarcinogenesis, and hematopoietic 
malignancies, etc. [75–81] Chang and Jia found Ougan 
(Citrus reticulata cv. Suavissima) flavedo extract exhib-
ited potential anti-tumor effects by its inhibitory effect 
on epithelial-to-mesenchymal transition and interfering 
with the canonical TGF-β1-SMAD-Snail/Slug axis [82].
Flavonoids
Pre- and post-treatment with naringenin effectively 
suppressed NDEA-initiated heap-tocarcinoma and the 
associated preneoplastic lesions by modulating xenobi-
otic-metabolizing enzymes, alleviating lipid peroxidation, 
and decreasing the levels of liver-marker enzymes [30]. 
Additionally, naringenin has also been documented in 
cadmium-induced hepatotoxicity and MNNG-induced 
gastric carcinogenesis [31, 32]. Supplemented hespere-
tin to DMH-treated rats suppressed the formation of 
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aberrant crypt foci and significantly reduced the activ-
ity of bacterial enzymes in colon cancer [27]. The results 
clearly revealed that dietary hesperetin possessed anti-
proliferative ability against chemically-induced colon 
tumorigenesis [28]. Apigenin was able to cause cell death 
of BxPC-3 and PANC-1 human pancreatic cancer cells 
by the inhibition of the GSK-3β/NF-κB signaling cas-
cade leading to the induction of apoptosis [83]. Ponci-
rin showed a significant in vitro inhibitory effect on the 
growth of the human gastric cancer cells, SGC-7901, in 
a dose-dependent manner [84]. Tangeretin caused arrest 
of the cell-cycle progression at the G1 phase and growth 
inhibition in the incubation of colon adenocarcinoma 
COLO 205 cells [35]. Quercetin was found to exhibit a 
suppressive effective in colon carcinogenesis and human 
cervical cancer cells, but it was found to be ineffective 
in mammary carcinogenesis [85]. Nobiletin (methoxy-
lated flavonoids) exerted inhibitory effects on the cell 
adhesion, invasion, and migration abilities of a highly 
metastatic AGS cells under non-cytotoxic concentrations 
through Ras/PI3K/AKT signaling pathway [39]. Polym-
ethoxyflavones from C. tamurana, C. tachibana and C. 
kinokuni show anticancer activity [43] The cytotoxicity 
of methoxylated flavonoids was higher than that of the 
hydroxylated analogues [86]. However, it was found that 
5-demethylnobiletin exhibited much stronger inhibitory 
effects on the growth of various cancer cells than nobi-
letin, suggesting the pivotal role of the hydroxyl group at 
the 5-position in the enhanced anti-cancer activity [87].
Limonoid
Limonoids, including methyl nomilinate, isoobacu-
noic acid, isolimonexic acid, and limonexic acid, were 
evaluated for their biological effects on SW480 human 
colon adenocarcinoma cells [88]. Among them, methyl 
nomilinate was the most potent inhibitor of cell meta-
bolic activity in MTT and EdU incorporation assays. 
A study reported that the anti-proliferative properties 
of limonoids from C. limon L. Burm were mediated by 
caspase-7-dependent pathways in breast cancer cells 
[89]. Moreover, their cytotoxic effect was more pro-
nounced in estrogen-responsive breast cancer cells. 
The combinations of limonoids and curcumin were 
effective in inducing apoptosis in SW480 cells [90]. 
Furthermore, limonoids and curcumin exhibited syner-
gistic inhibition of proliferation of colon cancer cells, 
which was supported by the total caspase-3 activity in 
the cells treated with combinations of limonoids and 
curcumin.
Coumarins
Oltipraz, auraptene, imperatorin, isopimpinellin, and 
auraptene all significantly increased liver cytosolic GST 
activities in Nrf2 heterozygous mice, suggesting anti-car-
cinogenic activities [91]. Besides, 5-geranyloxy-7-meth-
oxycoumarin, limettin, and isopimpinellin inhibited 
human colon cancer (SW-480) cell proliferation, with 
5-geranyloxy-7-methoxycoumar showing the highest 
inhibition activity (67 %) at 25 µm [92].
Carotenoids
β-Cryptoxanthin was reported to inhibit mouse skin 
tumorigenesis and rat colon carcinogenesis [93].
Cardiovascular protective effects
Large epidemiological studies frequently link increased 
consumption of flavonoid-rich foods with reduced 
cardiovascular morbidity and mortality [94] through 
the impact on blood lipid, blood glucose and vascular 
function. Herwandhani Putri found that Citrus hystrix 
kaffir lime’s peel ethanolic extract had potency to be 
developed as cardioprotector agent in chemotherapy 
[95].
Impact on blood lipid
Flavonoids A number of experiments suggested that 
Citrus-derived flavonoids may lower blood cholesterol 
(CH) and triglyceride (TG). Full methoxylation of the 
A-ring of Citrus flavonoids appeared to be the opti-
mal structure to express potent effects on modulat-
ing hepatic lipid metabolism via primarily suppressing 
apoB-containing lipoprotein secretion using HepG2 
cells [96]. Tangeretin and nobiletin, which have the 
optimal molecular structure, may lower blood CH and 
TG concentrations, whereas other Citrus flavonoids 
without a fully methoxylated A-ring may have virtually 
no or only weak lipid-lowering effects in humans such 
as hesperidin and naringin [36]. In high-fat fed Ldlr−/− 
mice, the addition of nobiletin resulted in a dramatic 
reduction in both hepatic and intestinal TG accumula-
tion, attenuation of very low-density lipoprotein(LDL)-
TG secretion and normalization of insulin sensitivity 
[40]. However, a study demonstrated that hydroxylated 
PMFs, such as 3′,4′-didemethylnobiletin and 5-demeth-
ylnobiletin, were more potent than permethoxylated 
nobiletin in inhibiting PMA-induced scavenger recep-
tor expression and modifying LDL uptake in THP-1 
cells [97].
Impact on blood glucose
Flavonoids Citrus flavonoids (hesperidin, naringin, 
neohesperidin, and nobiletin) significantly inhibited 
amylase-catalyzed starch digestion. Moreover, nar-
ingin and neohesperidin mainly inhibited amylose 
digestion, whereas hesperidin and nobiletin inhibited 
both amylose and amylopectin digestion. These results 
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demonstrated that Citrus flavonoids play important 
roles in preventing the progression of hyperglycemia, 
partly by binding to starch, increasing hepatic gly-
colysis and the glycogen concentration, and lowering 
hepatic gluconeogenesis [98]. Hesperidin, naringin, 
and nobiletin also exhibited antidiabetic activities, 
partly by lowering hepatic gluconeogenesis or improv-
ing insulin sensitivity in diabetic animals [99]. A study 
suggested that naringenin conferred protection against 
experimental diabetes through its antihyperglycemic 
and anti-oxidant properties in streptozotocin–nicoti-
namide-induced experimental diabetic rats [33]. In vivo 
chronic treatment of diabetic rats with naringenin could 
prevent the functional changes in vascular reactivity in 
diabetic rats through a NO-dependent and prostaglan-
din-independent pathway [34].
Impact on vascular function
Flavonoids Naringenin and hesperetin might exert 
anti-atherogenic effects partly through activating per-
oxisome proliferator-activated receptor and up-reg-
ulating adiponectin expression in adipocytes [100]. 
A study investigated the anti-atherosclerotic action 
and underlying mechanism of 5-demethylnobiletin in 
a cell-culture system and determined that 5-demeth-
ylnobiletin attenuated monocyte differentiation into 
macrophage and blunts foam cell formation by down 
regulating SR expression and activity [97]. This com-
pound also altered the lipid homeostasis in hepato-
cytes by up-regulating LDL receptor expression via 
steroid-response element-binding protein-2 activation 
and down-regulating diacylglycerol acyltransferases 
2 expression. In individuals with stage I hypertension, 
a double-blind crossover trial evaluated the effect on 
blood pressure of the consumption of a high-flavonoid 
Citrus juice compared to a low-flavonoid Citrus juice 
[101]. Only consumption of the high-flavonoid Citrus 
juice during 5 weeks resulted in a significant reduction 
in diastolic blood pressure (−3.7  mmHg). However, 
another controlled crossover trial involving individuals 
with metabolic syndrome had shown an improvement 
in flow-mediated dilation after a 3-week supplementa-
tion with 500  mg of hesperidin but with no effect on 
blood pressure [102].
Neuroprotective effects
In Ming Wu and Hongwu Zhang’s paper, they showed 
both C. aurantium L. aqueous extract and its major 
constituents (naringin, hesperidin, neohesperidin, and 
nobiletin) had neuroprotective effect on corticosterone-
induced neurotoxicity in PC12 cells. The in  vivo and 
in  vitro results suggest that C. aurantium L. aqueous 
extract had an antidepressant effect [103].
Flavonoids
The Citrus flavanones hesperidin, hesperetin, and neo-
hesperidin have neuroprotective activity against H2O2-
induced cytotoxicity in pheochromocytoma cell line 
(PC12 cells) by diverse mechanisms, including anti-
oxidant activity, regulation of intracellular calciumions, 
and inhibition of caspase-3 activity [104]. Hwang et  al. 
[105] tested the effect of Citrus flavonoids against oxi-
dative stress in PC12 cells, showing neuroprotection by 
the modulation of Akt/PKB, c-jun N-terminal kinase 
and P38 activation. Meanwhile, they also found flavo-
noids acted more as signaling molecules than as anti-
oxidants in this study. A pilot clinical study suggested the 
possibility that 1-year oral administration of decocted 
nobiletin-rich C. reticulata peel could be of benefit for 
improving the cognition of patients with Alzheimer’s dis-
ease, with no adverse side effects [41]. A study showed 
that 3,5,6,7,8,3′,4′-heptamethoxyflavone had the abil-
ity to induce brain-derived neurotrophic factor produc-
tion in astrocytes and enhance neurogenesis after brain 
ischemia, which may be mediated by activation of extra-
cellular signal-regulated kinases 1/2 (ERK1/2) and cAMP 
response element-binding protein [106].
Coumarins
Auraptene and 7-isopentenyloxycoumarin exerted pro-
tective effects against NMDA-induced excitatory neu-
rotoxicity in mixed cortical cell cultures [107]. Using a 
transient global ischemia mouse model, a study showed 
that auraptene effectively inhibited microglia activa-
tion, COX-2 expression by astrocytes, and neuronal cell 
death in the hippocampus following ischemic insults 
[108]. Auraptene had the ability to induce the activation 
of ERK1/2 in not only cortical neurons but also the rat 
PC12 cells and was able to promote neurite outgrowth 
from PC12 cells.
Other bioactivities
Apart from widely reported bioactivities mentioned 
above, other bioactivities of Citrus fruits from latest stud-
ies have also been reviewed (see Table 1).
Application of Citrus species
Citrus species are 131 million tons of fruits produced in 
2012 [6]. This large production is also relevant to the high 
consumption of Citrus fruits. Moreover, Citrus fruits 
rank first in international fruit trade in terms of its values 
of which cover fresh Citrus market and processed Citrus 
product market (such as food additives, spices, cosmetic 
ingredients, juice, jam, and chemotherapeutic drugs).
Given the plentiful bioactivities of Citrus fruits, the 
clinical use of them is of great significance. Investiga-
tion among 42,470 Japanese adults showed that Citrus 
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consumption was associated with reduced all-cancer 
incidence, especially for subjects that had simultaneously 
high green tea consumption [121]. A cross-sectional 
study (2031 elderly individuals) examined the relation-
ship between the intake of different plant foods and 
cognitive performance and found Citrus fruits had the 
strongest associations with mean test scores (positively) 
[122]. Another study found hesperidin (Citrus flavo-
noids) presented a better balance in bone metabolism on 
bone health [123]. And immature peels of citrus fruit are 
used to treat indigestion and have demonstrated poten-
tial as a chemotherapeutic agent [124, 125]. Many other 
studies have also shown that the consumption of Citrus 
fruits is associated with inhibition of various cancers, 
including colorectal, esophageal, and stomach cancer, 
as well as anti-stroke activity, improved blood lipid pro-
files and improved survival of the elderly [16]. And more 
and further studies are still required for Citrus species as 
chemotherapeutic drugs.
The consumption of Citrus fruits or juice is inversely 
associated with several diseases because of its abundant 
secondary metabolites. Almost 33 % of the Citrus fruits 
are industrially processed for juice production, however, 
where about half of processed Citrus including peels, 
segment membrane and seeds end up as wastes [126]. 
These solid residues are referred to as Citrus wastes with 
estimated worldwide production of 15 million tons per 
year [127]. What’s more, as reviewed in additional files, 
these Citrus wastes are still rich in various biologically 
secondary metabolites associated with human health. 
Citrus peel contains a high content of polymethoxylated 
flavones and flavanones, including primarily hesperi-
din, nobiletin, neohesperidin, naringin and tangeretin. 
A study suggested that hesperetin could be exploited as 
a potential functional ingredient and offered opportu-
nities to develop new formulations of functional foods 
[27]. Peels are also major source of essential oil as well 
as carotenoids, with approximately 70 % of the total fruit 
carotenoids, and their contents may be from two to six 
times higher than those of the endocarp [128]. Besides, 
seeds are the major sources of limonoids. Mayumi Mina-
misawa et al. have succeeded in extracting a large amount 
of limonoids from yuzu (Citrus junos) seeds which con-
tain higher amounts of fat-soluble limonoid aglycone 
(330.6  mg/g of dry seed), water-soluble limonoid glyco-
side (452.0 mg/g of dry seed), and oil (40 mg/g of green 
seed) [129]. Citrus species are noticeably beneficial fruits 
for consumption daily both for their nutrients contents 
and multiple active metabolites with related bioactivities, 
which manifests it is worthwhile to develop more useful 
recycling approaches of Citrus wastes. The applications 
given by Citrus wastes may help the industrial proces-
sors to find new ways of increasing the profit by recycling 
bioactive compounds and also reducing the considerable 
problem of wastes.
Conclusion and prospective
The multiple secondary metabolites in Citrus, including 
flavonoids, alkaloids, coumarins, limonoids, carotenoids, 
phenolic acids and volatile compounds, provide a rational 
basis for various biological activities. Among them, fla-
vonoids (especially flavanones, flavanonols and meth-
oxylated flavones) exhibit more bioactivities compared 
to other secondary metabolites. However, all these active 
metabolites work synergistically to exhibit anti-oxidative, 
anti-inflammatory, anti-cancer, anti-microbial and anti-
allergy effects, as well as presenting cardiovascular pro-
tection, neuroprotective effect, hepatoprotective effect, 
etc. Consequently, these multiple active metabolites with 
various bioactivities indicate that Citrus species are ben-
eficial fruits when eaten daily, both for their nutrients 
contents and as chemotherapeutic or complementary 
medicine to promote health. Furthermore, different spe-
cies, fruit parts, stages of maturity, environmental condi-
tions during growth, storage conditions and postharvest 
treatments can influence the level of active metabolites 
and related activities. And further investigations are 
required in order to make optimal use of these fruits.
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